TARBP2 and cancer: Different types of cancer cells, with diverse tissue origin, malignancy grade, metastatic potential, and mutational load, are shown to lack TRBP2 nuclear compartmentalization during mitosis, thereby opening new diagnostic and therapeutic windows for human malignancies in the clinic.